ATE417035T1 - Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen - Google Patents

Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen

Info

Publication number
ATE417035T1
ATE417035T1 AT05806455T AT05806455T ATE417035T1 AT E417035 T1 ATE417035 T1 AT E417035T1 AT 05806455 T AT05806455 T AT 05806455T AT 05806455 T AT05806455 T AT 05806455T AT E417035 T1 ATE417035 T1 AT E417035T1
Authority
AT
Austria
Prior art keywords
analogues
prevention
treatment
vitamin
bone diseases
Prior art date
Application number
AT05806455T
Other languages
English (en)
Inventor
Roger Bouillon
Annemieke Verstuyf
Clercq Pierre De
Maurits Vandewalle
Original Assignee
Leuven K U Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven K U Res & Dev filed Critical Leuven K U Res & Dev
Application granted granted Critical
Publication of ATE417035T1 publication Critical patent/ATE417035T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/21Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05806455T 2004-10-15 2005-10-17 Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen ATE417035T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0422929.0A GB0422929D0 (en) 2004-10-15 2004-10-15 Bioactive vitamin D analogues

Publications (1)

Publication Number Publication Date
ATE417035T1 true ATE417035T1 (de) 2008-12-15

Family

ID=33462778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05806455T ATE417035T1 (de) 2004-10-15 2005-10-17 Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen

Country Status (6)

Country Link
US (2) US7704986B2 (de)
EP (1) EP1809599B8 (de)
AT (1) ATE417035T1 (de)
DE (1) DE602005011661D1 (de)
GB (1) GB0422929D0 (de)
WO (1) WO2006039763A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060135491A1 (en) * 2004-12-06 2006-06-22 Roger Bouillon Vitamin D3 analog useful for the treatment of osteoporosis
WO2013105026A1 (en) 2012-01-09 2013-07-18 Department Of Biotechnology (Dbt) A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
ES2536256B2 (es) * 2013-11-20 2016-02-01 Universidade De Santiago De Compostela Análogos de vitamina d con interés farmacéutico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
PT707566E (pt) * 1993-07-09 2000-09-29 Theramex Novos analogos estruturais da vitamina d

Also Published As

Publication number Publication date
US20080032955A1 (en) 2008-02-07
DE602005011661D1 (de) 2009-01-22
US7704986B2 (en) 2010-04-27
US8258126B2 (en) 2012-09-04
EP1809599A1 (de) 2007-07-25
EP1809599B8 (de) 2012-04-04
EP1809599B1 (de) 2008-12-10
WO2006039763A1 (en) 2006-04-20
GB0422929D0 (en) 2004-11-17
US20100160455A1 (en) 2010-06-24
WO2006039763A8 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
EA201690265A3 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
ZA200706740B (en) Quinazolinone T-type calcium channel antagonists
TW200612892A (en) Novel compounds
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200630096A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
MXPA05011523A (es) Heteroarilos sustituidos como inhibidores de proteinas de tirosina fosfatasas.
NO20076413L (no) Multisykliske forbindelser og fremgangsmater for deres anvendelse
DE60120691D1 (de) Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen
MX2009003981A (es) Agentes moduladores del receptor de calcio.
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
DK1768748T3 (da) Sammensætninger omfattende strontium og vitamin D samt anvendelser deraf
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
DE60233261D1 (de) Inhibitoren von humanem adam-10
EP1879886A4 (de) Mitotische kinesinhemmer und verfahren zu ihrer verwendung
BRPI0514111B8 (pt) derivados de benzamidina, processo para a preparação destes e composição farmacêutica compreendendo os mesmos
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
ATE417035T1 (de) Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties